Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation

Akaru Ishida, Yoshitaka Miyakawa, Ryuji Tanosaki, Masatoshi Wakui, Hironori Ueno, Reiko Watanabe, Norihiro Awaya, Tomoyuki Tahara, Takashi Kato, Hiroshi Miyazaki, Atsushi Oda, Masahiro Kizaki, Shinichiro Okamoto, Yasuo Ikeda

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

To elucidate the physiologic role of thrombopoietin (TPO) for hematologic reconstitution following allogeneic bone marrow transplantation (BMT), serum TPO levels as well as interleukin-3 (IL-3), IL-6 and IL-11 were serially measured in 55 samples from 3 patients who underwent allogeneic BMT using an enzyme-linked immunosorbent assay (ELISA). The TPO level was higher in the serum taken during marrow aplasia than in the pretransplant serum. The serum TPO levels and platelet counts showed a strong inverse relationship in all patients examined. We also sequentially measured endogenous serum TPO levels before and within 36 h after platelet transfusions. Endogenous serum TPO levels were inversely correlated with platelet mass following platelet transfusions. Serum levels of IL-3 had no apparent correlation with platelet counts and serum levels of IL-11 remained below the detection levels (31.3 pg/ml) in all samples. Serum levels of IL-6 were high during myeloaplasia and more upregulated in the febrile period. These findings support the view that TPO is the central regulator for megakaryopoiesis in vivo and the rationale for its clinical use after allogeneic BMT.

Original languageEnglish
Pages (from-to)61-69
Number of pages9
JournalInternational Journal of Hematology
Volume65
Issue number1
Publication statusPublished - 1996 Dec

Fingerprint

Interleukin-11
Thrombopoietin
Interleukin-3
Homologous Transplantation
Bone Marrow Transplantation
Interleukin-6
Serum
Platelet Transfusion
Platelet Count
Fever
Blood Platelets
Bone Marrow
Enzyme-Linked Immunosorbent Assay

Keywords

  • Allogeneic bone marrow transplantation
  • Interleukin-11
  • Interleukin-3
  • Interleukin-6
  • Thrombopoietin

ASJC Scopus subject areas

  • Hematology

Cite this

Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation. / Ishida, Akaru; Miyakawa, Yoshitaka; Tanosaki, Ryuji; Wakui, Masatoshi; Ueno, Hironori; Watanabe, Reiko; Awaya, Norihiro; Tahara, Tomoyuki; Kato, Takashi; Miyazaki, Hiroshi; Oda, Atsushi; Kizaki, Masahiro; Okamoto, Shinichiro; Ikeda, Yasuo.

In: International Journal of Hematology, Vol. 65, No. 1, 12.1996, p. 61-69.

Research output: Contribution to journalArticle

Ishida, A, Miyakawa, Y, Tanosaki, R, Wakui, M, Ueno, H, Watanabe, R, Awaya, N, Tahara, T, Kato, T, Miyazaki, H, Oda, A, Kizaki, M, Okamoto, S & Ikeda, Y 1996, 'Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation', International Journal of Hematology, vol. 65, no. 1, pp. 61-69.
Ishida, Akaru ; Miyakawa, Yoshitaka ; Tanosaki, Ryuji ; Wakui, Masatoshi ; Ueno, Hironori ; Watanabe, Reiko ; Awaya, Norihiro ; Tahara, Tomoyuki ; Kato, Takashi ; Miyazaki, Hiroshi ; Oda, Atsushi ; Kizaki, Masahiro ; Okamoto, Shinichiro ; Ikeda, Yasuo. / Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation. In: International Journal of Hematology. 1996 ; Vol. 65, No. 1. pp. 61-69.
@article{96d07b2734094eafa2917ed68e4654f5,
title = "Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation",
abstract = "To elucidate the physiologic role of thrombopoietin (TPO) for hematologic reconstitution following allogeneic bone marrow transplantation (BMT), serum TPO levels as well as interleukin-3 (IL-3), IL-6 and IL-11 were serially measured in 55 samples from 3 patients who underwent allogeneic BMT using an enzyme-linked immunosorbent assay (ELISA). The TPO level was higher in the serum taken during marrow aplasia than in the pretransplant serum. The serum TPO levels and platelet counts showed a strong inverse relationship in all patients examined. We also sequentially measured endogenous serum TPO levels before and within 36 h after platelet transfusions. Endogenous serum TPO levels were inversely correlated with platelet mass following platelet transfusions. Serum levels of IL-3 had no apparent correlation with platelet counts and serum levels of IL-11 remained below the detection levels (31.3 pg/ml) in all samples. Serum levels of IL-6 were high during myeloaplasia and more upregulated in the febrile period. These findings support the view that TPO is the central regulator for megakaryopoiesis in vivo and the rationale for its clinical use after allogeneic BMT.",
keywords = "Allogeneic bone marrow transplantation, Interleukin-11, Interleukin-3, Interleukin-6, Thrombopoietin",
author = "Akaru Ishida and Yoshitaka Miyakawa and Ryuji Tanosaki and Masatoshi Wakui and Hironori Ueno and Reiko Watanabe and Norihiro Awaya and Tomoyuki Tahara and Takashi Kato and Hiroshi Miyazaki and Atsushi Oda and Masahiro Kizaki and Shinichiro Okamoto and Yasuo Ikeda",
year = "1996",
month = "12",
language = "English",
volume = "65",
pages = "61--69",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation

AU - Ishida, Akaru

AU - Miyakawa, Yoshitaka

AU - Tanosaki, Ryuji

AU - Wakui, Masatoshi

AU - Ueno, Hironori

AU - Watanabe, Reiko

AU - Awaya, Norihiro

AU - Tahara, Tomoyuki

AU - Kato, Takashi

AU - Miyazaki, Hiroshi

AU - Oda, Atsushi

AU - Kizaki, Masahiro

AU - Okamoto, Shinichiro

AU - Ikeda, Yasuo

PY - 1996/12

Y1 - 1996/12

N2 - To elucidate the physiologic role of thrombopoietin (TPO) for hematologic reconstitution following allogeneic bone marrow transplantation (BMT), serum TPO levels as well as interleukin-3 (IL-3), IL-6 and IL-11 were serially measured in 55 samples from 3 patients who underwent allogeneic BMT using an enzyme-linked immunosorbent assay (ELISA). The TPO level was higher in the serum taken during marrow aplasia than in the pretransplant serum. The serum TPO levels and platelet counts showed a strong inverse relationship in all patients examined. We also sequentially measured endogenous serum TPO levels before and within 36 h after platelet transfusions. Endogenous serum TPO levels were inversely correlated with platelet mass following platelet transfusions. Serum levels of IL-3 had no apparent correlation with platelet counts and serum levels of IL-11 remained below the detection levels (31.3 pg/ml) in all samples. Serum levels of IL-6 were high during myeloaplasia and more upregulated in the febrile period. These findings support the view that TPO is the central regulator for megakaryopoiesis in vivo and the rationale for its clinical use after allogeneic BMT.

AB - To elucidate the physiologic role of thrombopoietin (TPO) for hematologic reconstitution following allogeneic bone marrow transplantation (BMT), serum TPO levels as well as interleukin-3 (IL-3), IL-6 and IL-11 were serially measured in 55 samples from 3 patients who underwent allogeneic BMT using an enzyme-linked immunosorbent assay (ELISA). The TPO level was higher in the serum taken during marrow aplasia than in the pretransplant serum. The serum TPO levels and platelet counts showed a strong inverse relationship in all patients examined. We also sequentially measured endogenous serum TPO levels before and within 36 h after platelet transfusions. Endogenous serum TPO levels were inversely correlated with platelet mass following platelet transfusions. Serum levels of IL-3 had no apparent correlation with platelet counts and serum levels of IL-11 remained below the detection levels (31.3 pg/ml) in all samples. Serum levels of IL-6 were high during myeloaplasia and more upregulated in the febrile period. These findings support the view that TPO is the central regulator for megakaryopoiesis in vivo and the rationale for its clinical use after allogeneic BMT.

KW - Allogeneic bone marrow transplantation

KW - Interleukin-11

KW - Interleukin-3

KW - Interleukin-6

KW - Thrombopoietin

UR - http://www.scopus.com/inward/record.url?scp=0030560937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030560937&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 61

EP - 69

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 1

ER -